Cargando…

Block and replace therapy using propylthiouracil and levothyroxine for Graves’ disease during pregnancy

Detalles Bibliográficos
Autor principal:	Gupta, Vishal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401781/ https://www.ncbi.nlm.nih.gov/pubmed/22837941 http://dx.doi.org/10.4103/2230-8210.98039

Ejemplares similares

Pediatric Graves’ disease: management in the post-propylthiouracil Era
por: Rivkees, Scott A
Publicado: (2014)

Therapy with propylthiouracil for T3-predominant neonatal Graves’ disease: a case report
por: Hamajima, Emi, et al.
Publicado: (2018)

A CASE OF AUTOIMMUNE HEPATITIS WITH GRAVES’ DISEASE TREATED BY PROPYLTHIOURACIL
por: SATO, IKUKO, et al.
Publicado: (2011)

A Bizarre Complication of Levothyroxine Therapy
por: Joseph, Aneez, et al.
Publicado: (2021)

Propylthiouracil-related Toxic Hepatitis: Impact of Silent Cases
por: Eser, Murat, et al.
Publicado: (2015)

Adverse events related with propylthiouracil therapy of Graves’ Disease in children at Cipto Mangunkusumo Hospital Jakarta
por: Andriana, Novina, et al.
Publicado: (2013)

Management of a Pregnant Patient with Graves' Disease Complicated by Propylthiouracil induced Agranulocytosis
por: Cho, Yoon-Young, et al.
Publicado: (2005)

Accidental Levothyroxine Ingestion in a Child
por: Jagadishkumar, Kalenahalli, et al.
Publicado: (2013)

Reversible Hair Loss due to Levothyroxine Overdose
por: Yerawar, Chaitanya, et al.
Publicado: (2019)

Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis and agranulocytosis in a patient with Graves’ disease
por: Tomkins, Maria, et al.
Publicado: (2019)

Profile of Levothyroxine Replacement Therapy in Graves’ Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens
por: Mathiphanit, Saravut, et al.
Publicado: (2022)

Diffuse scalp hair loss due to levothyroxine overdose
por: Kumar, K. Jagadish, et al.
Publicado: (2015)

Diffuse scalp hair loss due to levothyroxine overdose
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Unilateral Graves' Disease
por: Mahalakshmi, VNSSVAMS D, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
por: Mengistu, Habtamu Solomon, et al.
Publicado: (2022)

Levothyroxine replacement and Ramadan fasting
por: Karoli, Ritu, et al.
Publicado: (2013)

Intellectual Development in Children Whose Mothers Received Propylthiouracil During Pregnancy
por: Burrow, Gerard N., et al.
Publicado: (1978)

Unmasking of Neuropsychiatric Manifestations after Total Thyroidectomy for Graves' Disease
por: Pradhan, Roma, et al.
Publicado: (2018)

The Differential Effects of Propylthiouracil and Methimazole as Graves’ Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial
por: Wisnu, Wismandari, et al.
Publicado: (2021)

Propylthiouracil-induced autoimmune disease
por: Paiaulla, Santosh, et al.
Publicado: (2015)

Comparison of Block and Replace Regime and Titration Regime in Graves’ Disease
por: Mar, Cho
Publicado: (2021)

Letter to “Levothyroxine absorption test results in patients with TSH elevation resistant to treatment”
por: Öztürk, Sadettin, et al.
Publicado: (2021)

Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients
por: Ratanapornsompong, Ganista, et al.
Publicado: (2021)

Long-Term Adherence to Levothyroxine Replacement Therapy in Thyroidectomized Patients
por: Bocale, Raffaella, et al.
Publicado: (2022)

Graves' disease presenting with acute renal infarction
por: Baek, Cho-Ok, et al.
Publicado: (2014)

De Novo Appearance of Pre-Tibial Myxedema After Radioactive Iodine Therapy for Graves’ Disease
por: Kuriakose, Cijoy K., et al.
Publicado: (2022)

Predicting the early risk of ophthalmopathy in Graves’ disease patients using TCR repertoire
por: Wang, Yue, et al.
Publicado: (2020)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
por: Anık, Ahmet
Publicado: (2022)

Graves’ Disease Thyrotoxicosis and Propylthiouracil Related Agranulocytosis Successfully Treated with Therapeutic Plasma Exchange and G-CSF Followed by Total Thyroidectomy
por: Candoni, Anna, et al.
Publicado: (2017)

Postpartum Management of Women Begun on Levothyroxine during Pregnancy
por: Stagnaro-Green, Alex
Publicado: (2015)

Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
por: Liu, Lu, et al.
Publicado: (2017)

Takotsubo Cardiomyopathy Associated with Levothyroxine Over-replacement
por: Balsa, Ana Margarida, et al.
Publicado: (2017)

Coincidence of remission of postpartum Graves' disease and use of omega-3 fatty acid supplements
por: Breese McCoy, Sarah J
Publicado: (2011)

Congenital Bands with Intestinal Malrotation after Propylthiouracil Exposure in Early Pregnancy
por: Leung, Alexander A., et al.
Publicado: (2015)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy
por: Bowman, Pamela, et al.
Publicado: (2011)

Effects of Levothyroxine Therapy on Pregnancy and Neonatal Outcomes in Subclinical Hypothyroidism
por: Luo, Jiaxi, et al.
Publicado: (2022)

Propylthiouracil Is Teratogenic in Murine Embryos
por: Benavides, Valeria C., et al.
Publicado: (2012)

Propylthiouracil-Induced Skin Vasculitis
por: Almeida, Mariana S, et al.
Publicado: (2022)

Graves' disease with thyroid hemiagenesis: A rare abnormality with rarer presentation
por: Philip, Rajeev, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b8jiqu74n9hsemkq3fdmplrgfh